Claudin18. 2 is a novel molecular biomarker for tumor-targeted immunotherapy

W Cao, H Xing, Y Li, W Tian, Y Song, Z Jiang, J Yu - Biomarker Research, 2022 - Springer
Abstract The claudin18. 2 (CLDN18. 2) protein, an isoform of claudin18, a member of the
tight junction protein family, is a highly selective biomarker with limited expression in normal …

Redox and metabolic regulation of intestinal barrier function and associated disorders

PY Lin, A Stern, HH Peng, JH Chen… - International Journal of …, 2022 - mdpi.com
The intestinal epithelium forms a physical barrier assembled by intercellular junctions,
preventing luminal pathogens and toxins from crossing it. The integrity of tight junctions is …

Streptococcus anginosus promotes gastric inflammation, atrophy, and tumorigenesis in mice

K Fu, AHK Cheung, CC Wong, W Liu, Y Zhou, F Wang… - Cell, 2024 - cell.com
Streptococcus anginosus (S. anginosus) was enriched in the gastric mucosa of patients with
gastric cancer (GC). Here, we show that S. anginosus colonized the mouse stomach and …

Context-dependent roles of claudins in tumorigenesis

J Li - Frontiers in Oncology, 2021 - frontiersin.org
The barrier and fence functions of the claudin protein family are fundamental to tissue
integrity and human health. Increasing evidence has linked claudins to signal transduction …

The preclinical discovery and development of zolbetuximab for the treatment of gastric cancer

Y Zeng, AC Lockhart, RU Jin - Expert Opinion on Drug Discovery, 2024 - Taylor & Francis
Introduction Gastric cancer remains a formidable challenge in oncology with high mortality
rates and few advancements in treatment. Claudin-18.2 (CLDN18. 2) is a tight junction …

Zolbetuximab for Claudin18. 2-positive gastric or gastroesophageal junction cancer

Y Kubota, K Shitara - Therapeutic Advances in Medical …, 2024 - journals.sagepub.com
Claudins (CLDNs) are a family of major membrane proteins that form components of tight
junctions. In normal tissues, CLDNs seal the intercellular space in the epithelial sheets to …

Pharmacological targeting of gastric mucosal barrier with traditional Chinese medications for repairing gastric mucosal injury

X Jia, Y He, L Li, D Xu - Frontiers in Pharmacology, 2023 - frontiersin.org
Introduction: The gastric mucosa (GM) is the first barrier and vital interface in the stomach
that protects the host from hydrochloric acid in gastric juice and defends against exogenous …

Expression and Targeted Application of Claudins Family in Hepatobiliary and Pancreatic Diseases

F Du, Y Xie, S Wu, M Ji, B Dong… - Journal of Hepatocellular …, 2024 - Taylor & Francis
Hepatobiliary and pancreatic diseases are becoming increasingly common worldwide and
associated cancers are prone to recurrence and metastasis. For a more accurate treatment …

The role of CLDN18. 2 in gastric cancer prognosis: a systematic review and meta-analysis

FCA Moraes, LE Rodrigues Sobreira… - Biomarkers, 2024 - Taylor & Francis
Background Gastric cancer (GC) is a major global cause of cancer mortality, with a median
overall survival of just 12 months. CLDN18. 2, a specific isoform of Claudin18 normally …

[HTML][HTML] Exploring banana phytosterols (Beta-sitosterol) on tight junction protein (claudin) as anti-urolithiasis contributor in Drosophila: a phyto-lithomic approach

AG Patil, JK Prakash, SS More… - Informatics in Medicine …, 2022 - Elsevier
Claudins are a class of transmembrane proteins in the family of tight junction (TJ) proteins.
The disrupted functioning of claudins has been found to have a role in urolithiasis (Kidney …